Present treatment of Guillain-Barre syndrome;Le traitement actuel du syndrome de Guillain-Barré

Bulletin de l'Academie Nationale de Medecine

Volumn 188, Issue 1, 2004, Pages 87-95

  Raphael, Jean Claude ^a   Queneau, Patrice ^b   Blancher, Gabriel ^b   Douste Blazy, Louis ^b   Chouard, Claude Henri ^b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b NONE

Author keywords

Guillain barre syndrome; Intravenous; Plasma exchange imunoglobulins; Randomized controlled trials

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ARTIFICIAL VENTILATION; CLINICAL TRIAL; DISEASE SEVERITY; DRUG ADMINISTRATION; GUILLAIN BARRE SYNDROME; HUMAN; INCIDENCE; MORTALITY; PLASMAPHERESIS; PROGNOSIS; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 4544381667     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33844-0     Document Type: Review

References (27)

1. GUILLAIN G., BARRÉ J.A., STROHL A. - Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Bull. Mem. Soc. Med. Hop. Paris, 1916, 1462-1470.
2. ROPPER A.H., WIJDICKS E.F.M., TRUAX B.T. - Guillain-Barré syndrome. Contemporary Neurology Series. F.A. Davis Company Ed. Philadelphia. 1991, 1 volume.
3. MCKHANN G.M., CORNBLATH D.R., HO T. et al. - Clinical and electrophysiological aspects of acute paralytic disease of children and young adults in northern China. Lancet, 1991, 338, 593-597.
4. ASBURY A.K., ARNASON B.G.W., KARP H.R., MCFARLIN D.E. - Criteria for the diagnosis of Guillain-Barré syndrome. Ann. Neurol., 1978, 3, 565-566.
5. RAPHAEL J.C., MASSON C., MORICE V. et al. - Le syndrome de Landry-Guillain-Barré. Étude des facteurs pronostiques dans 223 cas. Rev. Neurol., 1986, 142, 613-624.
6. FRENCH COOPERATIVE GROUP ON PLASMA EXCHANGE IN GUILLAIN-BARRŔ SYNDROME. - Efficiency of plasma exchange in Guillain-Barré syndrome : role of replacement fluids. Ann. Neurol., 1987, 22, 753-761.
7. FRENCH COOPERATIVE GROUP ON PLASMA EXCHANGE IN GUILLAIN-BARRÉ SYNDROME. - Appropriate number of plasma exchanges in Guillain-Barré Syndrome. Ann. Neurol., 1997, 41, 298-306.
8. PLASMA EXCHANGE/SANDOGLOBULIN GUILLAIN-BARRE SYNDROME TRIAL GROUP. - Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet, 1997, 349, 225-230.
9. VAN DER MECHÉ F.G.A., SCHMITZ P.I.M., and the dutch Guillain-Barré study group. - A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N. Engl. J. Med., 1992, 326, 1123-1129.
10. FRENCH COOPERATIVE GROUP ON PLASMA EXCHANGE IN GUILLAIN-BARRÉ SYNDROME. - Plasma exchange in Guillain-Barré syndrome : one-year follow-up. Ann. Neurol., 1992, 32, 94-97.
11. MCKHANN G.M., GRIFFIN J.W., CORNBLATH D.R., MELLITS E.D., FISHER R.S., QUASKEY S.A., AND THE GUILLAIN-BARRÉ SYNDROME STUDY GROUP. - Plasmapheresis and Guillain-Barré syndrome : analysis of prognostic factors and the effect of plasmapheresis. Ann. Neurol., 1988, 23, 347-353.
12. REES J.H., SOUDAIN S.E., GREGSON N.A., HUGUES R.A.C. - Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med., 1995, 333, 1374-1379.
13. WINER J.B., HUGUES R.A.C., GREENWOOD R.J., PERKIN G.D., HEALY M.J.R. - Prognosis in Guillain-Barré syndrome. Lancet, 1985, 1, 1202-1203.
14. HADDEN R.D.M., CORNBLATH D.R., HUGUES R.A.C. et al, and the plasma exchange/Sandoglobulin Guillain-Barré syndrome trial group. - Electrophysiological classification of Guillain-Barré syndrome : clinical associations and outcome. Ann. Neurol., 1998, 44, 780-788.
15. CHEVROLET J.C., DELEAMONT P. - Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome. Am. Rev. Respir. Dis., 1991, 144, 814-818.
16. ROPPER A.H. - Severe acute Guillain-Barré syndrome. Neurology, 1986, 36, 429-432.
17. LAWN N.D., FLETCHER D.D., HENDERSON R.D., WOLTER T.D., WIJDICKS E.F. - Anticipating mechanical ventilation in Guillain-Barré syndrome. Arch. Neurol., 2001, 58, 893-898.
18. SHARSHAR T., CHEVRET S., BOURDAIN F., RAPHAEL J.C. for the french cooperative group on plasma exchange in Guillain-Barré syndrome. - Early predictors of mechanical ventilation in Guillain-Barré syndrome. Crit. Care. Med., 2003, 31, 278-283.
19. OOMES P.G., VAN DER MECHÉ F.G.A., KLEYWEG R.P., and the dutch Guillain-Barré study group. - Liver function disturbances in Guillain-Barré syndrome : a prospective longitudinal study in 100 patients. Neurology, 1996, 46, 96-100.
20. HUGUES R.A.C., HADDEN R.D., GREGSON N.A., SMITH K.J. - Pathogenesis of Guillain-Barré syndrome. J. Neuroimmunol., 1999, 100, 74-97.
21. HUGUES R.A.C., RAPHAEL J.C., SWAN A.V., VAN DOOM P.A. - Intravenous exchange for Guillain-Barré syndrome. In : The Cochrane Database Syst. Rev., 2002, (2) : CD002063.
22. GUILLAIN-BARRÉ SYNDROME STEROID TRIAL GROUP. - Double-blind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet, 1993, 341, 586-590.
23. THE GUILLAIN-BARRÉ SYNDROME STUDY GROUP. - Plasmapheresis and acute Guillain-Barré syndrome. Neurology, 1985, 35, 1096-1104.
24. RAPHAEL J.C., CHEVRET S., HUGUES R.A.C., ANNANE D. - Plasma exchange for Guillain-Barré syndrome. In : The Cochrane Database Syst. Rev., 2002, : CD001798.
25. ESPEROU H., JARS-GUINCESTRE M.C., BOLGERT F., RAPHAEL J.C., DURAND-ZALESKI I., and the french cooperative group on plasma exchange in Guillain-Barré syndrome. - Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barré syndrome. Intensive Care M ed., 2000, 26, 1094-1100.
26. RAPHAEL J.C., CHEVRET S., HARBOUN M., JARS-GUINCESTRE M.C., for the french Guillain-Barré syndrome cooperative group. - Intravenous immune globulins in patients with Guillain-Barré syndrome and contraindications to plasma exchange : 3 days versus 6 days. J. Neurol. Neurosurg. Psychiatry, 2001, 71, 235-238.
27. HENDERSON R.D., LAWN N.D., FLETCHER D.D., MCCLELLAND R.L., WUDICKS EFM. - The morbidity of Guillain-Barré syndrome admitted to the intensive care unit. Neurology, 2003, 60, 17-21.